Jiangsu Skyray Instrument Past Earnings Performance
Past criteria checks 0/6
Jiangsu Skyray Instrument's earnings have been declining at an average annual rate of -62.7%, while the Medical Equipment industry saw earnings growing at 7.7% annually. Revenues have been growing at an average rate of 6.6% per year.
Key information
-62.7%
Earnings growth rate
-62.0%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 6.6% |
| Return on equity | -8.5% |
| Net Margin | -13.7% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Why Investors Shouldn't Be Surprised By Jiangsu Skyray Instrument Co., Ltd.'s (SZSE:300165) 28% Share Price Plunge
Apr 17
Returns On Capital At Jiangsu Skyray Instrument (SZSE:300165) Paint A Concerning Picture
Apr 15Jiangsu Skyray Instrument Co., Ltd.'s (SZSE:300165) Business And Shares Still Trailing The Industry
Feb 27Revenue & Expenses BreakdownBeta
How Jiangsu Skyray Instrument makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 961 | -132 | 319 | 89 |
| 31 Dec 23 | 1,017 | -114 | 322 | 84 |
| 30 Sep 23 | 1,201 | -78 | 297 | 76 |
| 30 Jun 23 | 1,269 | -100 | 311 | 84 |
| 31 Mar 23 | 1,244 | -116 | 328 | 79 |
| 31 Dec 22 | 1,290 | -104 | 337 | 80 |
| 30 Sep 22 | 1,316 | -95 | 340 | 79 |
| 30 Jun 22 | 1,559 | -69 | 349 | 71 |
| 31 Mar 22 | 1,578 | -44 | 347 | 73 |
| 01 Jan 22 | 1,542 | -54 | 348 | 75 |
| 30 Sep 21 | 1,325 | -1 | 320 | 74 |
| 30 Jun 21 | 1,035 | 55 | 309 | 70 |
| 31 Mar 21 | 1,000 | 20 | 327 | 68 |
| 31 Dec 20 | 936 | 21 | 309 | 59 |
| 30 Sep 20 | 858 | 24 | 308 | 61 |
| 30 Jun 20 | 827 | -27 | 313 | 67 |
| 31 Mar 20 | 869 | 19 | 287 | 64 |
| 31 Dec 19 | 908 | 21 | 298 | 72 |
| 30 Sep 19 | 961 | 8 | 355 | 79 |
| 30 Jun 19 | 986 | 42 | 311 | 69 |
| 31 Mar 19 | 995 | 32 | 316 | 71 |
| 31 Dec 18 | 1,024 | 36 | 307 | 69 |
| 30 Sep 18 | 1,002 | 84 | 261 | 63 |
| 30 Jun 18 | 948 | 84 | 237 | 95 |
| 31 Mar 18 | 888 | 110 | 223 | 79 |
| 31 Dec 17 | 792 | 104 | 220 | 64 |
| 30 Sep 17 | 593 | 70 | 207 | 42 |
| 30 Jun 17 | 518 | 61 | 233 | 0 |
| 31 Mar 17 | 461 | 59 | 211 | 0 |
| 31 Dec 16 | 430 | 56 | 202 | 0 |
| 30 Sep 16 | 382 | 58 | 184 | 0 |
| 30 Jun 16 | 357 | 54 | 180 | 0 |
| 31 Mar 16 | 337 | 47 | 176 | 0 |
| 31 Dec 15 | 321 | 45 | 173 | 0 |
| 30 Sep 15 | 289 | 47 | 166 | 0 |
| 30 Jun 15 | 285 | 56 | 162 | 0 |
| 31 Mar 15 | 274 | 49 | 165 | 0 |
| 31 Dec 14 | 277 | 50 | 165 | 0 |
| 30 Sep 14 | 295 | 56 | 175 | 0 |
| 30 Jun 14 | 309 | 51 | 181 | 0 |
| 31 Mar 14 | 317 | 56 | 185 | 0 |
| 31 Dec 13 | 325 | 56 | 192 | 0 |
| 30 Sep 13 | 320 | 69 | 185 | 0 |
| 30 Jun 13 | 311 | 61 | 183 | 0 |
Quality Earnings: 300165 is currently unprofitable.
Growing Profit Margin: 300165 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300165 is unprofitable, and losses have increased over the past 5 years at a rate of 62.7% per year.
Accelerating Growth: Unable to compare 300165's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 300165 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-0.5%).
Return on Equity
High ROE: 300165 has a negative Return on Equity (-8.48%), as it is currently unprofitable.